Cytosorbents Corp reports results for the quarter ended in December - Earnings Summary

Cytosorbents

09/03/2023 23:43

* Cytosorbents Corp  CTSO.OQ  reported a quarterly adjusted
loss
of 2 cents​​ per share for the quarter ended in December. The
mean expectation of five analysts for the quarter was for a loss
of 17 cents per share.
    * Revenue fell 12.9% to $9.39 million from a year ago;
analysts
expected $8.72 million. 
    * Cytosorbents Corp's reported EPS for the quarter was a
loss of 2
cents​.
    * The mean earnings estimate of analysts had risen by
about 5.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Cytosorbents Corp shares had risen by 140.6% this quarter.
    * The company reported a quarterly loss of $767 thousand.
    * Wall Street's median 12-month price target for
Cytosorbents Corp
is $6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
March 9 at 11:43 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2022      -0.17          -0.02          Beat
 Sep. 30 2022      -0.16          -0.28          Missed
 Jun. 30 2022      -0.13          -0.25          Missed
 Mar. 31 2022      -0.12          -0.21          Missed